Harvard Bioscience Inc
NASDAQ:HBIO
Harvard Bioscience Inc
NASDAQ:HBIO
Price:
0.5071
USD
-4.34%
Market Cap:
$22.7m
Relative Value
The Relative Value of one
HBIO
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 0.5071 USD,
Harvard Bioscience Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HBIO Relative Value
HIDDEN
Multiples Across Competitors
HBIO Competitors Multiples
Harvard Bioscience Inc Competitors
Harvard Bioscience Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Harvard Bioscience Inc
NASDAQ:HBIO
|
22.6m USD | 0.3 | -0.4 | 3.6 | -8.2 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
990.7B USD | 346.9 | 4 107.3 | 1 176.9 | 2 266.3 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
182.5B USD | 4 | 26.8 | 18.9 | 25.3 | |
| US |
|
Danaher Corp
NYSE:DHR
|
137.9B USD | 5.4 | 36.8 | 18.7 | 27.3 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
33.6B CHF | 5.2 | 35.5 | 26.5 | 26.5 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
265.7B CNY | 6 | 17.7 | 17.8 | 17.8 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
32.6B USD | 4.5 | 24.6 | 19.3 | 23.1 | |
| US |
|
Waters Corp
NYSE:WAT
|
29.2B USD | 8.9 | 44 | 28.5 | 35.8 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.1B USD | 1.7 | 20.8 | 11.7 | 17.5 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25B USD | 6 | 27.9 | 20.8 | 23.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
